- Home
- Publications
- Publication Search
- Publication Details
Title
Immune imprinting and next-generation coronavirus vaccines
Authors
Keywords
-
Journal
Nature Microbiology
Volume 8, Issue 11, Pages 1971-1985
Publisher
Springer Science and Business Media LLC
Online
2023-11-07
DOI
10.1038/s41564-023-01505-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recalling ancestral SARS-CoV-2 variants: is it an original sin with benefits?
- (2023) Sebastian Hoehl et al. LANCET INFECTIOUS DISEASES
- Neutralization of BA.4–BA.5, BA.4.6, BA.2.75.2, BQ.1.1, and XBB.1 with Bivalent Vaccine
- (2023) Jing Zou et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bivalent Covid-19 Vaccines — A Cautionary Tale
- (2023) Paul A. Offit NEW ENGLAND JOURNAL OF MEDICINE
- Immunogenicity of BA.5 Bivalent mRNA Vaccine Boosters
- (2023) Ai-ris Y. Collier et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibody Response to Omicron BA.4–BA.5 Bivalent Booster
- (2023) Qian Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- The impact of cross-reactive immunity on the emergence of SARS-CoV-2 variants
- (2023) Robin N. Thompson et al. Frontiers in Immunology
- Immunological imprinting: Understanding COVID-19
- (2023) Marios Koutsakos et al. IMMUNITY
- The ups and downs of observational vaccine research
- (2023) Noam Barda LANCET INFECTIOUS DISEASES
- SARS-CoV-2 Omicron boosting induces de novo B cell response in humans
- (2023) Wafaa B. Alsoussi et al. NATURE
- High-dimensional analysis of 16 SARS-CoV-2 vaccine combinations reveals lymphocyte signatures correlating with immunogenicity
- (2023) Nicolás Gonzalo Nuñez et al. NATURE IMMUNOLOGY
- Predicting the efficacy of variant-modified COVID-19 vaccine boosters
- (2023) David S. Khoury et al. NATURE MEDICINE
- An influenza H1 hemagglutinin stem-only immunogen elicits a broadly cross-reactive B cell response in humans
- (2023) Sarah F. Andrews et al. Science Translational Medicine
- An influenza hemagglutinin stem nanoparticle vaccine induces cross-group 1 neutralizing antibodies in healthy adults
- (2023) Alicia T. Widge et al. Science Translational Medicine
- Evolution of antibody immunity following Omicron BA.1 breakthrough infection
- (2023) Chengzi I. Kaku et al. Nature Communications
- The imprinting effect of covid-19 vaccines: an expected selection bias in observational studies
- (2023) Susana Monge et al. BMJ-British Medical Journal
- Timeline of changes in spike conformational dynamics in emergent SARS-CoV-2 variants reveal progressive stabilization of trimer stalk with altered NTD dynamics
- (2023) Sean M Braet et al. eLife
- Glycan masking of a non-neutralising epitope enhances neutralising antibodies targeting the RBD of SARS-CoV-2 and its variants
- (2023) George W. Carnell et al. Frontiers in Immunology
- Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
- (2023) Devaki Pilapitiya et al. EBioMedicine
- Original SARS-CoV-2 monovalent and Omicron BA.4/BA.5 bivalent COVID-19 mRNA vaccines: phase 2/3 trial interim results
- (2023) Spyros Chalkias et al. NATURE MEDICINE
- Progressive loss of conserved spike protein neutralizing antibody sites in Omicron sublineages is balanced by preserved T cell immunity
- (2023) Alexander Muik et al. Cell Reports
- A computationally designed antigen eliciting broad humoral responses against SARS-CoV-2 and related sarbecoviruses
- (2023) Sneha Vishwanath et al. Nature Biomedical Engineering
- Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
- (2022) Katharina Röltgen et al. CELL
- Germinal centre-driven maturation of B cell response to mRNA vaccination
- (2022) Wooseob Kim et al. NATURE
- Towards SARS-CoV-2 serotypes?
- (2022) Etienne Simon-Loriere et al. NATURE REVIEWS MICROBIOLOGY
- Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants
- (2022) Catherine J. Reynolds et al. SCIENCE
- Development of Receptor Binding Domain (RBD)‐Conjugated Nanoparticle Vaccines with Broad Neutralization against SARS‐CoV‐2 Delta and Other Variants
- (2022) Ran Chen et al. Advanced Science
- Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine
- (2022) Rishi R. Goel et al. CELL
- Protective prototype-Beta and Delta-Omicron chimeric RBD-dimer vaccines against SARS-CoV-2
- (2022) Kun Xu et al. CELL
- A comprehensive review about immune responses and exhaustion during coronavirus disease (COVID-19)
- (2022) Rebar N. Mohammed et al. Cell Communication and Signaling
- Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019
- (2022) James D. Allen et al. JOURNAL OF VIROLOGY
- Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
- (2022) Frauke Muecksch et al. NATURE
- Immune response to SARS-CoV-2 after a booster of mRNA-1273: an open-label phase 2 trial
- (2022) Laurence Chu et al. NATURE MEDICINE
- Efficacy and Safety of the RBD-Dimer–Based Covid-19 Vaccine ZF2001 in Adults
- (2022) Lianpan Dai et al. NEW ENGLAND JOURNAL OF MEDICINE
- Memory B cell diversity: insights for optimized vaccine design
- (2022) Joshua J.C. McGrath et al. TRENDS IN IMMUNOLOGY
- SARS-CoV-2 vaccination washes away original antigenic sin
- (2022) Shiv Pillai TRENDS IN IMMUNOLOGY
- Opposing Effects of Prior Infection versus Prior Vaccination on Vaccine Immunogenicity against Influenza A(H3N2) Viruses
- (2022) Annette Fox et al. Viruses-Basel
- Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants
- (2022) Yin-Feng Kang et al. Nature Communications
- Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19
- (2022) Wouter L. Smit et al. Frontiers in Immunology
- Omicron BA.1 breakthrough infection drives cross-variant neutralization and memory B cell formation against conserved epitopes
- (2022) Jasmin Quandt et al. Science Immunology
- Recall of pre-existing cross-reactive B cell memory following Omicron BA.1 breakthrough infection
- (2022) Chengzi I. Kaku et al. Science Immunology
- Fatal COVID-19 outcomes are associated with an antibody response targeting epitopes shared with endemic coronaviruses
- (2022) Anna L. McNaughton et al. JCI Insight
- BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection
- (2022) Yunlong Cao et al. NATURE
- Mosaic RBD nanoparticles protect against challenge by diverse sarbecoviruses in animal models
- (2022) Alexander A. Cohen et al. SCIENCE
- Immune boosting by B.1.1.529 ( Omicron) depends on previous SARS-CoV-2 exposure
- (2022) Catherine J. Reynolds et al. SCIENCE
- SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
- (2022) Kevin W. Ng et al. Science Translational Medicine
- Interval between prior SARS-CoV-2 infection and booster vaccination impacts magnitude and quality of antibody and B cell responses
- (2022) Clarisa M. Buckner et al. CELL
- Memory B cell responses to Omicron subvariants after SARS-CoV-2 mRNA breakthrough infection in humans
- (2022) Zijun Wang et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trial
- (2022) Spyros Chalkias et al. NATURE MEDICINE
- A Bivalent Omicron-Containing Booster Vaccine against Covid-19
- (2022) Spyros Chalkias et al. NEW ENGLAND JOURNAL OF MEDICINE
- Immune Imprinting and Protection against Repeat Reinfection with SARS-CoV-2
- (2022) Hiam Chemaitelly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
- (2022) Young-Jun Park et al. SCIENCE
- Does repeated influenza vaccination attenuate effectiveness? A systematic review and meta-analysis
- (2022) Elenor Jones-Gray et al. Lancet Respiratory Medicine
- Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants
- (2022) Qian Wang et al. CELL
- Extensive Recombination-driven Coronavirus Diversification Expands the Pool of Potential Pandemic Pathogens
- (2022) Stephen A Goldstein et al. Genome Biology and Evolution
- Antigenic Landscape Analysis of Individuals Vaccinated with a Universal Influenza Virus Vaccine Candidate Reveals Induction of Cross-Subtype Immunity
- (2022) Philip Meade et al. JOURNAL OF VIROLOGY
- Effect of hybrid immunity and bivalent booster vaccination on omicron sublineage neutralisation
- (2022) Markus Hoffmann et al. LANCET INFECTIOUS DISEASES
- Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster
- (2022) Chaitanya Kurhade et al. NATURE MEDICINE
- Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster
- (2022) Meredith E. Davis-Gardner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022
- (2022) Ruth Link-Gelles et al. MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT
- Natural and hybrid immunity following four COVID-19 waves: A prospective cohort study of mothers in South Africa
- (2022) Heather J. Zar et al. EClinicalMedicine
- Potential impact of individual exposure histories to endemic human coronaviruses on age-dependent severity of COVID-19
- (2021) Francesco Pinotti et al. BMC Medicine
- Evolution of antibody immunity to SARS-CoV-2
- (2021) Christian Gaebler et al. NATURE
- The antigenic anatomy of SARS-CoV-2 receptor binding domain
- (2021) Wanwisa Dejnirattisai et al. CELL
- Maturation and persistence of the anti-SARS-CoV-2 memory B cell response
- (2021) Aurélien Sokal et al. CELL
- Seasonal human coronavirus antibodies are boosted upon SARS-CoV-2 infection but not associated with protection
- (2021) Elizabeth M. Anderson et al. CELL
- Next generation methodology for updating HA vaccines against emerging human seasonal influenza A(H3N2) viruses
- (2021) James D. Allen et al. Scientific Reports
- Profiling B cell immunodominance after SARS-CoV-2 infection reveals antibody evolution to non-neutralizing viral targets
- (2021) Haley L. Dugan et al. IMMUNITY
- Quadrivalent influenza nanoparticle vaccines induce broad protection
- (2021) Seyhan Boyoglu-Barnum et al. NATURE
- SARS-CoV-2 in severe COVID-19 induces a TGF-β-dominated chronic immune response that does not target itself
- (2021) Marta Ferreira-Gomes et al. Nature Communications
- Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
- (2021) Alexandra C. Walls et al. CELL
- SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2
- (2021) Fatima Amanat et al. CELL
- Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variants
- (2021) Saya Moriyama et al. IMMUNITY
- Naturally enhanced neutralizing breadth against SARS-CoV-2 one year after infection
- (2021) Zijun Wang et al. NATURE
- Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors
- (2021) Chee-Wah Tan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
- (2021) David R. Martinez et al. SCIENCE
- Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection
- (2021) Allison J. Greaney et al. Science Translational Medicine
- Immunological imprinting of the antibody response in COVID-19 patients
- (2021) Teresa Aydillo et al. Nature Communications
- Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4+ T cell help
- (2021) Jernej Pušnik et al. Cell Reports
- Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection
- (2021) Qibin Geng et al. PLoS Pathogens
- Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
- (2021) Tom Woudenberg et al. EBioMedicine
- Early cross-coronavirus reactive signatures of humoral immunity against COVID-19
- (2021) Paulina Kaplonek et al. Science Immunology
- Evidence for increased SARS-CoV-2 susceptibility and COVID-19 severity related to pre-existing immunity to seasonal coronaviruses
- (2021) Paul R. Wratil et al. Cell Reports
- A bivalent nanoparticle vaccine exhibits potent cross-protection against the variants of SARS-CoV-2
- (2021) Yaochang Yuan et al. Cell Reports
- Influenza Vaccines Delivered in Early Childhood Could Turn Antigenic Sin into Antigenic Blessings
- (2020) Michael Worobey et al. Cold Spring Harbor Perspectives in Medicine
- Original Antigenic Sin: How Original? How Sinful?
- (2020) Jonathan W. Yewdell et al. Cold Spring Harbor Perspectives in Medicine
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV
- (2020) Meng Yuan et al. SCIENCE
- Cross-reactive Antibody Response between SARS-CoV-2 and SARS-CoV Infections
- (2020) Huibin Lv et al. Cell Reports
- Tailored design of protein nanoparticle scaffolds for multivalent presentation of viral glycoprotein antigens
- (2020) George Ueda et al. eLife
- Overcoming Symmetry Mismatch in Vaccine Nanoassembly via Spontaneous Amidation
- (2020) Mark Howarth et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Loss of Bcl-6-Expressing T Follicular Helper Cells and Germinal Centers in COVID-19
- (2020) Naoki Kaneko et al. CELL
- Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
- (2020) Luca Piccoli et al. CELL
- Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19
- (2020) Matthew C. Woodruff et al. NATURE IMMUNOLOGY
- Advances in nanomaterial vaccine strategies to address infectious diseases impacting global health
- (2020) Chelsea N. Fries et al. Nature Nanotechnology
- Viral epitope profiling of COVID-19 patients reveals cross-reactivity and correlates of severity
- (2020) Ellen Shrock et al. SCIENCE
- Temporal signal and the phylodynamic threshold of SARS-CoV-2
- (2020) Sebastian Duchene et al. Virus Evolution
- Recent endemic coronavirus infection is associated with less-severe COVID-19
- (2020) Manish Sagar et al. JOURNAL OF CLINICAL INVESTIGATION
- Prior presumed coronavirus infection reduces COVID-19 risk: A cohort study
- (2020) Dvir Aran et al. JOURNAL OF INFECTION
- A chimeric hemagglutinin-based universal influenza virus vaccine approach induces broad and long-lasting immunity in a randomized, placebo-controlled phase I trial
- (2020) Raffael Nachbagauer et al. NATURE MEDICINE
- A computationally designed H5 antigen shows immunological breadth of coverage and protects against drifting avian strains
- (2019) Ted M. Ross et al. VACCINE
- Mosaic nanoparticle display of diverse influenza virus hemagglutinins elicits broad B cell responses
- (2019) Masaru Kanekiyo et al. NATURE IMMUNOLOGY
- Original antigenic sin shapes the immunological repertoire evoked by HCMV gB-MF59 vaccine in seropositive recipients
- (2019) Ilona Baraniak et al. JOURNAL OF INFECTIOUS DISEASES
- Development of Influenza B Universal Vaccine Candidates Using the “Mosaic” Hemagglutinin Approach
- (2019) Weina Sun et al. JOURNAL OF VIROLOGY
- Outflanking immunodominance to target subdominant broadly neutralizing epitopes
- (2019) Davide Angeletti et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
- (2019) Felix Broecker et al. npj Vaccines
- Original Antigenic Sin and Respiratory Syncytial Virus Vaccines
- (2019) Ralph A. Tripp et al. Vaccines
- Current challenges: from the path of “original antigenic sin” towards the development of universal flu vaccines
- (2019) Asim Biswas et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Injection of Antibodies against Immunodominant Epitopes Tunes Germinal Centers to Generate Broadly Neutralizing Antibodies
- (2019) Michael Meyer-Hermann Cell Reports
- Childhood immune imprinting to influenza A shapes birth year-specific risk during seasonal H1N1 and H3N2 epidemics
- (2019) Katelyn M. Gostic et al. PLoS Pathogens
- Engineering a Rugged Nanoscaffold to Enhance Plug-and-Display Vaccination
- (2018) Theodora Ulli Jordanka Bruun et al. ACS Nano
- From Original Antigenic Sin to the Universal Influenza Virus Vaccine
- (2018) Carole Henry et al. TRENDS IN IMMUNOLOGY
- Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic
- (2018) Alain Gagnon et al. mBio
- A naturally protective epitope of limited variability as an influenza vaccine target
- (2018) Craig P. Thompson et al. Nature Communications
- The evolution of seasonal influenza viruses
- (2017) Velislava N. Petrova et al. NATURE REVIEWS MICROBIOLOGY
- Negative impact of prior influenza vaccination on current influenza vaccination among people infected and not infected in prior season: A test-negative case-control study in Japan
- (2017) Nobuo Saito et al. VACCINE
- Analysis of Anti-Influenza Virus Neuraminidase Antibodies in Children, Adults, and the Elderly by ELISA and Enzyme Inhibition: Evidence for Original Antigenic Sin
- (2017) Madhusudan Rajendran et al. mBio
- Targeted Elimination of Immunodominant B Cells Drives the Germinal Center Reaction toward Subdominant Epitopes
- (2017) Murillo Silva et al. Cell Reports
- Functional balance between neuraminidase and haemagglutinin in influenza viruses
- (2016) A. Gaymard et al. CLINICAL MICROBIOLOGY AND INFECTION
- Antibodies Against the Current Influenza A(H1N1) Vaccine Strain Do Not Protect Some Individuals From Infection With Contemporary Circulating Influenza A(H1N1) Virus Strains
- (2016) Joshua G. Petrie et al. JOURNAL OF INFECTIOUS DISEASES
- Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting
- (2016) Katelyn M. Gostic et al. SCIENCE
- The Quest for a Universal Flu Vaccine: Headless HA 2.0
- (2015) Florian Krammer Cell Host & Microbe
- Longitudinal analysis of the peripheral B cell repertoire reveals unique effects of immunization with a new influenza virus strain
- (2015) Bernardo Cortina-Ceballos et al. Genome Medicine
- Is Antigenic Sin Always “Original?” Re-examining the Evidence Regarding Circulation of a Human H1 Influenza Virus Immediately Prior to the 1918 Spanish Flu
- (2015) Alain Gagnon et al. PLoS Pathogens
- Humans and Ferrets with Prior H1N1 Influenza Virus Infections Do Not Exhibit Evidence of Original Antigenic Sin after Infection or Vaccination with the 2009 Pandemic H1N1 Influenza Virus
- (2014) Christopher D. O'Donnell et al. Clinical and Vaccine Immunology
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- CD80 and PD-L2 define functionally distinct memory B cell subsets that are independent of antibody isotype
- (2014) Griselda V Zuccarino-Catania et al. NATURE IMMUNOLOGY
- Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season
- (2014) S. L. Linderman et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular Signatures of Hemagglutinin Stem-Directed Heterosubtypic Human Neutralizing Antibodies against Influenza A Viruses
- (2014) Yuval Avnir et al. PLoS Pathogens
- Guiding the Immune Response against Influenza Virus Hemagglutinin toward the Conserved Stalk Domain by Hyperglycosylation of the Globular Head Domain
- (2013) D. Eggink et al. JOURNAL OF VIROLOGY
- Age-Specific Mortality During the 1918 Influenza Pandemic: Unravelling the Mystery of High Young Adult Mortality
- (2013) Alain Gagnon et al. PLoS One
- Global Mortality Estimates for the 2009 Influenza Pandemic from the GLaMOR Project: A Modeling Study
- (2013) Lone Simonsen et al. PLOS MEDICINE
- Elimination of Germinal-Center-Derived Self-Reactive B Cells Is Governed by the Location and Concentration of Self-Antigen
- (2012) Tyani D. Chan et al. IMMUNITY
- Strategies to alleviate original antigenic sin responses to influenza viruses
- (2012) J. H. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China
- (2012) Justin Lessler et al. PLoS Pathogens
- Prevalence of Antibodies against Seasonal Influenza A and B Viruses in Children in Netherlands
- (2011) R. Bodewes et al. Clinical and Vaccine Immunology
- Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
- (2011) Jens Wrammert et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Age-specific mortality risk from pandemic influenza
- (2011) Junling Ma et al. JOURNAL OF THEORETICAL BIOLOGY
- Boosting antibody responses by targeting antigens to dendritic cells
- (2011) Irina Caminschi et al. TRENDS IN IMMUNOLOGY
- Original Antigenic Sin Responses to Influenza Viruses
- (2009) J. H. Kim et al. JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started